These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3787030)

  • 1. [Practice of specific desensitization in allergology].
    Frei PC
    Rev Med Suisse Romande; 1986 Oct; 106(10):901-8. PubMed ID: 3787030
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergen vaccines for specific diagnosis.
    Larsen JN; Løwenstein H
    Clin Allergy Immunol; 2000; 15():1-51. PubMed ID: 10943287
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyposensitization in general practice. A strategic concept].
    Jorde W
    HNO; 1995 Dec; 43(12):741-4. PubMed ID: 8582837
    [No Abstract]   [Full Text] [Related]  

  • 4. Sublingual administration of allergen desensitization.
    Reiber ME
    Tenn Med; 2002 Nov; 95(11):465-7. PubMed ID: 12436862
    [No Abstract]   [Full Text] [Related]  

  • 5. Advantages and disadvantages of accelerated immunotherapy schedules.
    Cox L
    J Allergy Clin Immunol; 2008 Aug; 122(2):432-4. PubMed ID: 18619664
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyposensitization].
    Przybilla B; Ring J
    Internist (Berl); 1991 Oct; 32(10):606-11. PubMed ID: 1761393
    [No Abstract]   [Full Text] [Related]  

  • 7. Future of allergen-specific immunotherapy: better understanding of the mechanisms, novel treatments, and long-term cure.
    Akdis CA
    Immunol Allergy Clin North Am; 2006 May; 26(2):xiii-xxii. PubMed ID: 16701138
    [No Abstract]   [Full Text] [Related]  

  • 8. LAIS - Posological schedules.
    Bruno M
    Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):33-4. PubMed ID: 17761105
    [No Abstract]   [Full Text] [Related]  

  • 9. [Desensitization with allergens: early, specific, effective therapy of immune system almost without side effects. Interview by Dr. Barbara Scholtissek].
    Fiebig H; Kahlert H
    Wien Med Wochenschr; 1999; 149(14-15):447, 449-50. PubMed ID: 10584292
    [No Abstract]   [Full Text] [Related]  

  • 10. Treating allergy: where to from here?
    O'Hehir RE
    Intern Med J; 2009 Aug; 39(8):491-4. PubMed ID: 19732196
    [No Abstract]   [Full Text] [Related]  

  • 11. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy.
    Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D
    J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349
    [No Abstract]   [Full Text] [Related]  

  • 12. Standardization of allergen-specific immunotherapy vaccines.
    Spangfort MD; Larsen JN
    Immunol Allergy Clin North Am; 2006 May; 26(2):191-206, v-vi. PubMed ID: 16701140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide immunotherapy.
    Larché M
    Immunol Allergy Clin North Am; 2006 May; 26(2):321-32, viii. PubMed ID: 16701147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAIS Allergoid.
    Mistrello G
    Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):21-4. PubMed ID: 17761102
    [No Abstract]   [Full Text] [Related]  

  • 15. [The immunological background of the allergen vaccines application].
    Rogala B
    Wiad Lek; 1999; 52(11-12):539-46. PubMed ID: 10745688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyposensitization in allergic diseases?].
    Fuchs E
    Dtsch Med Wochenschr; 1988 Jun; 113(25):1025-8. PubMed ID: 3289877
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral routes for immunotherapy: clinical efficacy and kinetics of the allergen.
    Canonica GW; Passalacqua G; Mariani G; Motta C; Bartolomei M; Mistrello G; Falagiani P; Bagnasco M
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):56-64; discussion 64-7. PubMed ID: 9383892
    [No Abstract]   [Full Text] [Related]  

  • 18. How to stop the allergy march.
    Lopes Dos Santos JM
    Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):39-40. PubMed ID: 17761107
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trials with recombinant allergens: research studies?
    Pauli G
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():257-64; discussion 264-5. PubMed ID: 20799469
    [No Abstract]   [Full Text] [Related]  

  • 20. Histamine receptors in immune regulation and allergen-specific immunotherapy.
    Jutel M; Blaser K; Akdis CA
    Immunol Allergy Clin North Am; 2006 May; 26(2):245-59, vii. PubMed ID: 16701143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.